Login
Business
Entertainment
World
Health
Environment
Lifestyle
National
Science
Sports
World
Movies
Web Series
Technology
Cricket
Coronavirus
Auto
Ajab Ghazab
Finance
India
International
Religious
Politics
Home Articles Science Translational Medicine
Study reveals existing medicines prevent to cause kidney disease \
4 min read
\
\

Study reveals existing medicines prevent to cause kidney disease

 15-Dec-2022
According to a new study, serious illness that can cause the kidneys to suddenly stop working could be addressed with existing medications.
15-Dec-2022 Health
\
Acute kidney injuries could be treated by widely available medicinal drugs: Study \
4 min read
\
\

Acute kidney injuries could be treated by widely available medicinal drugs: Study

 15-Dec-2022
Widely available medicines could assist in lessening the impact of acute kidney injuries before they could cause complications and damage, as per a study published in Science Translational Medicine.
15-Dec-2022 Health
\
Study reveals why Alzheimer’s disease destroys specific areas of brain \
6 min read
\
\

Study reveals why Alzheimer’s disease destroys specific areas of brain

 17-Nov-2022
A study revealed why certain parts of the brain are particularly vulnerable to Alzheimer's damage. It comes down to the gene APOE, the greatest genetic risk factor for Alzheimer's disease. The parts of the brain where APOE is most active are the areas that sustain the most damage, they found.
17-Nov-2022 Health
\
Sugar molecules as a target in cancer therapy: Research \
4 min read
\
\

Sugar molecules as a target in cancer therapy: Research

 08-Nov-2022
Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism can be neutralized.
08-Nov-2022 Health
\
New injectable gel shows potential for tough-to-treat brain tumours \
5 min read
\
\

New injectable gel shows potential for tough-to-treat brain tumours

 13-Aug-2022
Wisconsin [US], August 13 (ANI): In most cases, months after the patient's first tumour is surgically removed, glioblastoma recurs, like the hardest weed. Due to this, the survival rates for this cancer are only 25% after one year and drop to 5% after five years.
13-Aug-2022 Health
\
New injectable gel holds promise for tough-to-treat brain tumours \
5 min read
\
\

New injectable gel holds promise for tough-to-treat brain tumours

 09-Aug-2022
Wisconsin [US], August 9 (ANI): Like the toughest weed, Glioblastoma almost always returns, typically months after the patient's initial brain tumour is surgically removed. Because of this, the survival rates for this cancer are only 25% after one year and drop to 5% after five years.
09-Aug-2022 Health
\
Use of anti-inflammatory drug in treating patients with severe COVID-19 \
4 min read
\
\

Use of anti-inflammatory drug in treating patients with severe COVID-19

 21-Jul-2022
Houston [US], July 21 (ANI): According to a new study from UTHealth Houston and other institutions, an anti-inflammatory drug may have the ability to treat systemic inflammation and brain damage in patients with severe COVID-19 and greatly lower their risk of dying.
21-Jul-2022 Health
\
Cancer drug has potential to treat muscular dystrophy: Study \
5 min read
\
\

Cancer drug has potential to treat muscular dystrophy: Study

 02-Jul-2022
Washington [US], July 2 (ANI): According to a new study, a group of researchers found that a cancer drug available at present could have the potential to treat muscular dystrophy.
02-Jul-2022 Health
\
Study finds Calcium is vital not just for bones but also heart \
4 min read
\
\

Study finds Calcium is vital not just for bones but also heart

 23-Jan-2022
Suita [Japan], January 23 (ANI): The human heart, the size of a fist, located just behind and slightly left of the breastbone, tirelessly beats an average of 100,000 times a day. However, conditions that stop the heart from pumping blood efficiently can cause serious problems and ultimately require a heart transplantation.
23-Jan-2022 Health
\
Preclinical studies supports US Army’s pan-coronavirus vaccine development strategy \
4 min read
\
\

Preclinical studies supports US Army’s pan-coronavirus vaccine development strategy

 22-Dec-2021
Washington [US], December 22 (ANI): The Spike Ferritin Nanoparticle (SpFN) COVID-19 vaccine developed by researchers at the Walter Reed Army Institute of Research (WRAIR) not only elicits a potent immune response but may also provide broad protection against SARS-CoV-2 variants of concern as well as other coronaviruses, according to a series of recently published preclinical study.
22-Dec-2021 World
\